A new, simple blood test could transform breast cancer treatment by accurately matching women to the right therapies and tracking the disease's evolution, potentially eliminating the need for invasive biopsies, researchers suggest.
This innovation addresses a critical challenge: breast cancer's diverse forms each demand specific treatments, yet around one in five advanced tumours can alter their type, rendering existing therapies ineffective.
